RxSight Inc. logo

RxSight Inc.

RXST | NASDAQ
Chart Builder DCF Calculator
$5.14
-$0.06 (-1.15%)
At close: Sep 21, 2026, 4:00 PM ET
$5.06
-$0.08 (-1.56%)
Pre-market: Sep 22, 2026, 7:35 AM ET

Company Profile

As a medical technology enterprise, RxSight, Inc. (which operated as Calhoun Vision, Inc. until its rebranding in February 2017) specializes in the innovation, manufacturing, and distribution of light-adjustable intraocular lenses (LALs). These advanced lenses are specifically designed for use in cataract surgery, serving patients in both domestic and international markets. The cornerstone of the company's offerings is the RxSight system, a sophisticated solution that enables ophthalmologists to precisely tailor and enhance a patient's visual acuity following cataract removal. An integral part of this system is the RxSight light delivery device, an in-office instrument. This device emits UV light in a carefully controlled pattern to modify the LAL, thereby ensuring optimal visual correction after the surgical procedure. RxSight's primary clientele consists of eye surgeons specializing in cataract treatments. The company was founded in 1997 and its corporate headquarters are situated in Aliso Viejo, California.

Key Executives

Name Position
Aziz Mottiwala President, Chief Executive Officer & Director
Ilya Goldshleger Chief Operating Officer
Mark Wilterding Chief Financial Officer
Adam Dashe Executive Vice President of International
Eric J. Weinberg Chief Business Development Officer
Jim Schindler Executive VP & General Counsel
Maureen O'Connell Executive Vice President of Clinical & Regulatory Affairs
Oliver Moravcevic Vice President of Investor Relations
Patrick Cullen Executive Vice President of Quality & Infrastructure Operations
Ronald Kurtz Chief Medical Officer
Trent Campbell Executive VP of US Sales & Commercial Strategy

Latest SEC Filings

Date Type Title
Sep 02, 2026 4 Filing
Sep 02, 2026 4 Filing
Sep 02, 2026 4 Filing
Sep 02, 2026 4 Filing
Aug 25, 2026 SC TO-I/A [Amend] Filing
Aug 19, 2026 SC 13G Statement of acquisition of beneficial ownership b...
Aug 10, 2026 SC TO-I Filing
Aug 05, 2026 10-Q Quarterly Report
Aug 05, 2026 8-K Current Report
Aug 04, 2026 SC 13G/A [Amend] Statement of acquisition of beneficial own...
View All SEC Filings
RxSight Inc.
RxSight Inc. logo
Country United States
IPO Date Jul 29, 2021
Industry Medical - Devices
Sector Healthcare
Employees 461
CEO Aziz Mottiwala

Contact Details

100 Columbia Aliso Viejo, California 92656 United States

Stock Details

Ticker Symbol RXST
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001111485
CUSIP Number 78349D107
ISIN Number US78349D1072
SIC Code 3851

© 2026 bestshares.com. All rights reserved.